Soluble crystallins were fractionated using a 2.5 × 95-cm
column (Sephacryl S-300 HR; Amersham Pharmacia Biotech, Piscataway, NJ)
maintained at 4°C. The mobile phase buffer contained 20 mM Tris (pH
7.5), 1.0 mM EGTA, and 100 mM NaCl and flowed at 25 mL/h. Collected
peaks of α-, βH-, βL-, and γ-crystallins were then concentrated
and desalted by ultrafiltration (YM10 membranes; Millipore, Bedford,
MA) and dried by vacuum centrifugation. Individual βH-crystallin
subunits were isolated by anion-exchange HPLC using a 7.5 × 75-mm
diethylaminoethyl (DEAE) column (5-PW; TosoHaas, Montgomeryville, PA).
Before chromatography, βH-crystallin aggregates were denatured and
reduced by dissolving in 6 M urea, 10 mM Tris (pH 8.5), 50 mM
dithiothreitol (DTT), and incubation at 37°C for 30 minutes. The DEAE
column mobile phase contained 6 M urea, 10 mM Tris (pH 8.5), and 2 mM
DTT at a 1-mL/min flow rate. Three to 10 mg βH was injected, and
after a 15-minute wash, β-subunits were eluted with a 0- to 80-mM
NaCl gradient over 100 minutes.